Crescent Biopharma, Inc. · NASDAQ:CBIO
Crescent Biopharma, Inc. shareholders
As of Sep 30, 2026, 101 institutions reported holding Crescent Biopharma, Inc. Largest: Fidelity, Fairmount Funds Management LLC and Bvf Inc. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | As of |
|---|---|---|---|
| Fidelity | 5.9M | US$86.2M | Sep 30, 2026 |
| Fairmount Funds Management LLC | 3.6M | US$52.5M | Sep 30, 2026 |
| Bvf Inc | 3.09M | US$45.1M | Sep 30, 2026 |
| Vestal Point Capital, LP | 3M | US$43.8M | Sep 30, 2026 |
| BlackRock | 2.14M | US$31.2M | Sep 30, 2026 |
| Venrock Adviser, LLC | 2.13M | US$31.1M | Sep 30, 2026 |
| Fcpm III Services B.V. | 2.02M | US$29.5M | Sep 30, 2026 |
| Vanguard | 1.79M | US$26.1M | Sep 30, 2026 |
| Opaleye Management Inc. | 1.65M | US$24M | Sep 30, 2026 |
| Balyasny Asset Management L.P. | 1.61M | US$23.5M | Sep 30, 2026 |
| Tang Capital Management LLC | 1.16M | US$16.9M | Sep 30, 2026 |
| Jennison Associates LLC | 1.1M | US$16.1M | Sep 30, 2026 |
| Blackstone Inc. | 1.06M | US$15.5M | Sep 30, 2026 |
| Logos Global Management LP | 850K | US$12.4M | Sep 30, 2026 |
| State Street | 843K | US$12.3M | Sep 30, 2026 |
| Geode Capital | 735K | US$10.7M | Sep 30, 2026 |
| Perceptive Advisors LLC | 707K | US$10.3M | Sep 30, 2026 |
| Ameriprise | 681K | US$9.93M | Sep 30, 2026 |
| Adage Capital Partners Gp, L.L.C. | 500K | US$7.29M | Sep 30, 2026 |
| Siren, L.L.C. | 400K | US$5.84M | Sep 30, 2026 |
| Rtw Investments, LP | 373K | US$5.44M | Sep 30, 2026 |
| NEXTBio Capital Management LP | 373K | US$5.44M | Sep 30, 2026 |
| Remedium Capital Partners, LLC | 361K | US$5.27M | Sep 30, 2026 |
| Squadron Capital Management LLC | 350K | US$5.11M | Sep 30, 2026 |
| Citadel | 350K | US$5.1M | Sep 30, 2026 |
| Sphera Funds Management LTD. | 280K | US$4.08M | Sep 30, 2026 |
| Woodline Partners LP | 270K | US$3.93M | Sep 30, 2026 |
| ADAR1 Capital Management, LLC | 231K | US$3.38M | Sep 30, 2026 |
| Northern Trust | 230K | US$3.36M | Sep 30, 2026 |
| Goldman Sachs | 227K | US$3.32M | Sep 30, 2026 |
| Two Sigma | 211K | US$3.08M | Sep 30, 2026 |
| UBS | 207K | US$3.01M | Sep 30, 2026 |
| Sectoral Asset Management Inc | 168K | US$2.45M | Sep 30, 2026 |
| Ikarian Capital, LLC | 150K | US$2.19M | Sep 30, 2026 |
| Nuveen | 145K | US$2.11M | Sep 30, 2026 |
| Marshall Wace, LLP | 131K | US$1.92M | Sep 30, 2026 |
| Seven Grand Managers, LLC | 100K | US$1.46M | Sep 30, 2026 |
| Schwab | 93,663 | US$1.37M | Sep 30, 2026 |
| Bank of America | 90,646 | US$1.32M | Sep 30, 2026 |
| Millennium | 84,896 | US$1.24M | Sep 30, 2026 |
| XTX Topco Ltd | 80,064 | US$1.17M | Sep 30, 2026 |
| Algert Global LLC | 75,957 | US$1.11M | Sep 30, 2026 |
| Burkehill Global Management, LP | 74,000 | US$1.08M | Sep 30, 2026 |
| Wellington | 73,086 | US$1.07M | Sep 30, 2026 |
| BNY | 67,826 | US$990K | Sep 30, 2026 |
| Susquehanna | 55,725 | US$813K | Sep 30, 2026 |
| Boothbay Fund Management, LLC | 42,794 | US$624K | Sep 30, 2026 |
| Quadrature Capital Ltd | 41,175 | US$601K | Sep 30, 2026 |
| Schonfeld Strategic Advisors LLC | 32,349 | US$472K | Sep 30, 2026 |
| T. Rowe Price | 32,326 | US$472K | Sep 30, 2026 |
This page holds 50 of 101 holders.
Funds
This page holds 50 of 80 holders.
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| Peter Harwin | 16.52% | 6.6M | Jul 16, 2026 | Schedule 13D |
| FMR LLC | 15.00% | 4.13M | Dec 31, 2025 | Schedule 13G |
| BVF PARTNERS L P/IL | 9.80% | 3.69M | Sep 30, 2026 | Schedule 13G |
| Vestal Point Capital, LP | 8.10% | 3M | Sep 30, 2026 | Schedule 13G |
| ForGrowth III PA B.V. | 6.10% | 1.68M | Dec 8, 2025 | Schedule 13G |
| Venrock Healthcare Capital Partners III, L.P. | 5.90% | 2.23M | Sep 30, 2026 | Schedule 13G |
| BlackRock, Inc. | 5.60% | 2.08M | Sep 30, 2026 | Schedule 13G |